Prothena | PRTA - PE Price to Earnings

Stock Price
9.76
Daily Change
-0.10 -1.01%
Monthly
-7.22%
Yearly
35.93%
Q2 Forecast
9.47

Prothena reported 22.11 in PE Price to Earnings for its fiscal quarter ending in March of 2022.





Pe Change Date
Acadia Pharmaceuticals 10.08 1.53 Mar/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Akebia Therapeutics 1.63K 1.6K Dec/2025
ALKERMES 39.33 19.8 Mar/2026
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
Amgen 19.84 5.47 Mar/2026
Biogen 13.7 0.32 Mar/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Exelixis 13.91 588.4 Mar/2026
Incyte 15.35 0.51 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Neurocrine Biosciences 28.09 807.38 Mar/2026
Prothena 22.11 11.37 Mar/2022
Regeneron Pharmaceuticals 25.14 7.03 Mar/2026
Vertex Pharmaceuticals 25.82 0.33 Mar/2026
Xoma 52.12 3.09 Sep/2022